Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
5
×
boston blog main
life sciences
national blog main
biotech
boston top stories
clinical trials
national top stories
amgen
deals
inclisiran
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
alirocumab
evolocumab
fda
hepatitis b
alexion pharmaceuticals
beijing
boehringer ingelheim
boston
brii bio
brii biosciences
china
cholesterol
dicerna pharamceuticals
drugs
evercore isi
glaxosmithkline
gsk
heart attack
hepatitis b virus
hereditary transthyretin amyloidosis
joseph swartz
medicines co.
novartis
What
drug
5
×
medicines
5
×
cholesterol
medco
new
disease
fda
hepatitis
lowering
pharmaceuticals
acquire
adds
agreed
alliance
alnylam
areas
based
billion
biosciences
bio’s
brii
bringing
brings
cash
caught
causing
clears
closer
company
compound
data
deal
dicerna
earlier
evidence
eye
filing
gene
heart
inched
Language
unset
Current search:
medicines
×
drug
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline